Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

48
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
48
Tumor Immunotherapy01:27

Tumor Immunotherapy

785
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
785
Regulation of Metabolism01:19

Regulation of Metabolism

10.5K
Cellular needs and conditions vary from cell to cell and change within individual cells over time. For example, the required enzymes and energetic demands of stomach cells are different from those of fat storage cells, skin cells, blood cells, and nerve cells. Furthermore, a digestive cell works much harder to process and break down nutrients during the time that closely follows a meal compared with many hours after a meal. As these cellular demands and conditions vary, so do the amounts and...
10.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The PLK4 inhibitor RP-1664 demonstrates potent efficacy in neuroblastoma preclinical models through a dual mechanism of sensitivity.

Nature communications·2026
Same author

BCL-2 and MCL1 co-inhibition enhances glucocorticoid therapy in preclinical models of infant KMT2A-rearranged acute lymphoblastic leukaemia.

British journal of haematology·2026
Same author

Polyamine depletion limits progression of acute leukaemia.

International journal of cancer·2025
Same author

The polyamine transporter ATP13A3 mediates difluoromethylornithine-induced polyamine uptake in neuroblastoma.

Molecular oncology·2025
Same author

FDA-approved disulfiram as a novel treatment for aggressive leukemia.

Journal of molecular medicine (Berlin, Germany)·2024
Same author

Delivery of PEGylated liposomal doxorubicin by bispecific antibodies improves treatment in models of high-risk childhood leukemia.

Science translational medicine·2023

Related Experiment Video

Updated: Oct 31, 2025

Immunometabolic Circuits in Infection for Advancing Host Directed Therapies
11:12

Immunometabolic Circuits in Infection for Advancing Host Directed Therapies

Published on: September 13, 2024

621

Immunometabolism: A 'Hot' Switch for 'Cold' Pediatric Solid Tumors.

Lin Xiao1, Harrison Yeung2, Michelle Haber1

  • 1Children's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales Sydney, NSW 2052, Australia; School of Women's and Children's Health, University of New South Wales Sydney, Randwick, NSW 2052, Australia.

Trends in Cancer
|June 29, 2021
PubMed
Summary

Pediatric solid tumors evade immune attack, hindering immunotherapy. Targeting tumor metabolism offers a novel strategy to enhance immunotherapy effectiveness in children with solid cancers.

Keywords:
immune coldimmunometabolismimmunotherapypediatric solid tumors

More Related Videos

Predictive Immune Modeling of Solid Tumors
08:50

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

7.2K
Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:04

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

895

Related Experiment Videos

Last Updated: Oct 31, 2025

Immunometabolic Circuits in Infection for Advancing Host Directed Therapies
11:12

Immunometabolic Circuits in Infection for Advancing Host Directed Therapies

Published on: September 13, 2024

621
Predictive Immune Modeling of Solid Tumors
08:50

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

7.2K
Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:04

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

895

Area of Science:

  • Oncology
  • Immunology
  • Metabolic pathways

Background:

  • Immunotherapies show success in adult cancers and pediatric blood cancers, but not pediatric solid tumors.
  • Pediatric solid tumors possess mechanisms to evade the immune system, limiting current immunotherapy efficacy.
  • Altered tumor metabolism is a key factor in immune evasion within pediatric solid tumors.

Purpose of the Study:

  • To review metabolic alterations in pediatric solid tumors that promote immune escape.
  • To discuss novel strategies targeting these metabolic pathways.
  • To explore the potential of combining metabolic targeting with immunotherapy for pediatric solid cancers.

Main Methods:

  • Literature review of metabolic pathways in pediatric solid tumors.
  • Analysis of current antimetabolic strategies.
  • Exploration of potential therapeutic combinations and translational challenges.

Main Results:

  • Pediatric solid tumors exhibit specific metabolic reprogramming that supports immune evasion.
  • Targeting these metabolic pathways presents a promising avenue for overcoming immunotherapy resistance.
  • Combination of antimetabolic strategies with immunotherapies could enhance treatment efficacy.

Conclusions:

  • Metabolic reprogramming in pediatric solid tumors is a critical target for improving immunotherapy outcomes.
  • Novel antimetabolic strategies hold potential for potentiating immunotherapies in pediatric solid cancers.
  • Further research and preclinical testing are needed to translate these findings into clinical applications, particularly through personalized medicine approaches.